News for 'COV'

Women can get Covid vaccine anytime after delivery: Experts

Women can get Covid vaccine anytime after delivery: Experts

Rediff.com23 May 2021

"Pregnancy doesn't increase the risk of acquiring SARS-COV-2 infection but appears to worsen the clinical course as compared to non-pregnant women'

Top medical body favours phased school reopening

Top medical body favours phased school reopening

Rediff.com28 Sep 2021

Evidence indicates that restoration of functioning of the education system as it was in pre-Covid times, as early as possible appears prudent in the current Indian context, they said.

India expects 500 million doses of Covid vaccine by July 2021

India expects 500 million doses of Covid vaccine by July 2021

Rediff.com13 Oct 2020

"Keeping a close pace with the potential availability of vaccine, a plan of action on which sections are to be given priority has been discussed. Importantly, it would be monitored through a scientific approach," Dr Harsh Vardhan told ANI about the strategy being discussed on vaccine distribution.

How long before the world gets a COVID-19 vaccine?

How long before the world gets a COVID-19 vaccine?

Rediff.com28 Apr 2020

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.

Kerala man worships 'Corona Devi' to ward off COVID-19

Kerala man worships 'Corona Devi' to ward off COVID-19

Rediff.com14 Jun 2020

Many in the social media have questioned his motive, while others have said he was doing it just for publicity and some said it was just superstition.

How US companies are helping India fight coronavirus

How US companies are helping India fight coronavirus

Rediff.com16 Apr 2020

A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.

'Severity, deaths not higher, but more transmissible'

'Severity, deaths not higher, but more transmissible'

Rediff.com2 Apr 2021

'People are just putting the mask below their nose.' 'They are only protecting the mouth, but not the nose.' 'People need to understand that it is the nose which has to be protected.'

8 Asiatic lions in Hyderabad zoo test Covid positive

8 Asiatic lions in Hyderabad zoo test Covid positive

Rediff.com4 May 2021

8 Asiatic lions in the zoo in have tested positive for COVID-19 after their saliva samples were thoroughly examined by CSIR-Centre for Cellular and Molecular Biology in Hyderabad, Rakesh Mishra, advisor of the premier research institute said.

Focus on double vaccination first: Experts amid calls for booster

Focus on double vaccination first: Experts amid calls for booster

Rediff.com4 Dec 2021

'Scientific data has proven that masks can reduce COVID-91 transmission by 53 per cent...A booster dose of vaccine, even if it works, is just a temporary fix'

Can you spread COVID-19 by talking?

Can you spread COVID-19 by talking?

Rediff.com16 May 2020

Why a new study suggests you wear a face mask when you speak to anyone.

COVID: 'Treatment gets very challenging'

COVID: 'Treatment gets very challenging'

Rediff.com23 Jul 2021

'When you are on these drugs, there is a possibility that you come to the hospital late, just by virtue of the fact that you believe that things are going to turn around, because you are on all these medicines.'

Covid patients' symptoms persist for a year: Lancet study

Covid patients' symptoms persist for a year: Lancet study

Rediff.com27 Aug 2021

The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with Covid-19.

Covid: First Indian to get Trump cocktail discharged from hospital

Covid: First Indian to get Trump cocktail discharged from hospital

Rediff.com26 May 2021

Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the "single dose infusion-based treatment" on Tuesday and then kept under observation.

3rd wave may peak between Oct-Nov: Govt panel scientist

3rd wave may peak between Oct-Nov: Govt panel scientist

Rediff.com4 Jul 2021

However, Covid infection can spread faster during the third wave if any new virulent variant of SARS-CoV-2 emerges, said Manindra Agarwal who is working with the Sutra Model -- the mathematical projection of the COVID-19 trajectory.

No proof Covid 2nd wave due to variants: Virologist

No proof Covid 2nd wave due to variants: Virologist

Rediff.com26 Mar 2021

There is so far no evidence that the second wave of COVID-19 in the country is due to variants of the virus, but it is possible, said noted virologist Shahid Jameel.

Who shouldn't take jab? Vaccine makers issue fact sheet

Who shouldn't take jab? Vaccine makers issue fact sheet

Rediff.com19 Jan 2021

The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.

Is A Vaccine Booster Needed?

Is A Vaccine Booster Needed?

Rediff.com20 Dec 2021

'There is no emergency of a third wave that we are rushing for booster doses.'

China offers its COVID vaccine to diplomats, foreign scribes

China offers its COVID vaccine to diplomats, foreign scribes

Rediff.com18 Mar 2021

A notice issued to the foreign journalists on Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group. Sinopharm's COVID-19 vaccine has been granted conditional market approval by China's National Medical Products Administration.

57% of Mumbai's slum dwellers have covid antibodies: Study

57% of Mumbai's slum dwellers have covid antibodies: Study

Rediff.com29 Jul 2020

The sero-surveillance started on June 3 and 6,936 samples out of an estimated 8,870 were collected from slum and non-slum population of three civic wards -- R-North, M-West and F-North -- in the first half of July.

Anti-Covid drug developed by DRDO cleared for emergency use

Anti-Covid drug developed by DRDO cleared for emergency use

Rediff.com8 May 2021

It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

Researchers spot distinct features in lungs of COVID-19 victims

Researchers spot distinct features in lungs of COVID-19 victims

Rediff.com22 May 2020

According to the study, both SARS-CoV-2 and H1N1 are the same category of virus, and both infect the respiratory tract. While the lungs of both groups shared some common features, the scientists said there were distinctive features related to blood vessels seen in the lungs of patients who had died due to COVID-19.

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

IIT-Delhi launches coronavirus kit, claimed to be world's most affordable

Rediff.com15 Jul 2020

The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.

Lockdown will no longer help in COVID-19 fight: Virologist

Lockdown will no longer help in COVID-19 fight: Virologist

Rediff.com23 May 2020

Shahid Jameel, recipient of Shanti Swarup Bhatnagar Prize for Science and Technology, also said that the country had already reached community transmission a long time ago.

How we can DEFEAT COVID-19

How we can DEFEAT COVID-19

Rediff.com3 Dec 2020

'If our body is able to mount a very successful immune response, we can negate the virus.'

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

DRDO's Covid drug: Benefits. Concerns

DRDO's Covid drug: Benefits. Concerns

Rediff.com31 May 2021

Commercial launch and supply to major government and private hospitals is expected in mid-June.

Covid spread in 5 states a cause for concern: Govt

Covid spread in 5 states a cause for concern: Govt

Rediff.com10 Aug 2021

The Reproduction number or Rt refers to how many people an infected person infects on average. In other words, it can tell how efficiently a virus is spreading.

Covid: Big 3rd wave unlikely in India, say experts

Covid: Big 3rd wave unlikely in India, say experts

Rediff.com23 Nov 2021

Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.

Cotton, silk, chiffon best materials for masks: Study

Cotton, silk, chiffon best materials for masks: Study

Rediff.com25 Apr 2020

The scientists assessed the ability of common fabrics, alone or in combination, to filter out aerosols similar in size to respiratory droplets.

COVID-19 test method developed by IIT Delhi gets ICMR nod

COVID-19 test method developed by IIT Delhi gets ICMR nod

Rediff.com23 Apr 2020

IIT Delhi is the first academic institute to have obtained the ICMR approval for a real-time PCR- based diagnostic assay. The development also comes against the backdrop of the Indian Council of Medical Research halting the testing for COVID-19 cases through China-made test kits because of massive variation in test results, compounding the challenge to check and contain the pandemic.

Why are COVID-19 cases increasing?

Why are COVID-19 cases increasing?

Rediff.com26 Mar 2021

'We really need to look seriously to see if there are any local variants.'

'Economy can bounce back, but the dead won't come back'

'Economy can bounce back, but the dead won't come back'

Rediff.com6 May 2021

'Unless some serious steps like complete closedown are taken, it will have disastrous consequences.'

Oxford COVID-19 vaccine hopes rise with strong trial results

Oxford COVID-19 vaccine hopes rise with strong trial results

Rediff.com16 Jul 2020

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and 'killer T-cells', a senior source from the trial was quoted by The Daily Telegraph as saying.

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Pfizer, BioNTech claim their Covid vaccine over 90% effective

Rediff.com10 Nov 2020

After discussion with the Food and Drug Administration (FDA), the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases, the statement said.

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

Govt plans rapid pool testing of migrants, returnees from abroad

Govt plans rapid pool testing of migrants, returnees from abroad

Rediff.com14 May 2020

The same testing technique would also be used for monitoring in green zones districts which have reported no cases till now or in the last 21 days, the Union health ministry said while issuing 'Guidelines for RT-PCR based pooled sampling for migrants/returnees from abroad/green zones'.

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

7-day institutional quarantine for all UK flyers arriving in Delhi

7-day institutional quarantine for all UK flyers arriving in Delhi

Rediff.com8 Jan 2021

Travellers coming from the United Kingdom to the national capital will have to undergo a seven-day institutional quarantine and a seven-day home quarantine even if they test negative for COVID-19 on arrival, Chief Minister Arvind Kejriwal announced on Friday.

More premium trains likely in Rail Budget

More premium trains likely in Rail Budget

Rediff.com4 Jul 2014

The premium trains will be the focus area as the project has been the revenue generator for the loss-making passenger operations

Double mutant found in 61% samples tested in Maharashtra

Double mutant found in 61% samples tested in Maharashtra

Rediff.com14 Apr 2021

However, experts in the fields of genome sequencing and cell science have observed that such a small sample size cannot be considered as an indication of the spread of the mutated virus.